Journal article
Dabigatran Versus Warfarin in Patients With Atrial Fibrillation
Abstract
BACKGROUND: The Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial compared dabigatran 110 mg BID (D110) and 150 mg BID (D150) with warfarin for stroke prevention in 18 113 patients with nonvalvular atrial fibrillation.
METHODS AND RESULTS: Cardioversion on randomized treatment was permitted. Precardioversion transesophageal echocardiography was encouraged, particularly in dabigatran-assigned patients. Data from before, …
Authors
Nagarakanti R; Ezekowitz MD; Oldgren J; Yang S; Chernick M; Aikens TH; Flaker G; Brugada J; Kamenský G; Parekh A
Journal
Circulation, Vol. 123, No. 2, pp. 131–136
Publisher
Wolters Kluwer
Publication Date
January 18, 2011
DOI
10.1161/circulationaha.110.977546
ISSN
0009-7322